AFO
ABBV icon

Arrowroot Family Office’s AbbVie ABBV Stock Holding History

Arrowroot Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Sell
949
-110
-10% -$23.7K 0.07% 160
2026
Q1 		$230K Buy
+1,059
New +$235K 0.08% 146
2025
Q4 		– Sell
-1,375
Closed -$318K – 141
2025
Q3 		$318K Buy
+1,375
New +$280K 0.13% 111
2024
Q4 		$204K Buy
+1,146
New +$211K 0.11% 129

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Arrowroot Family Office's ABBV Position: Q2 2026 in Review

Arrowroot Family Office reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $23.7K and leaving 949 shares worth $239K. The position accounts for 0.07% of the portfolio, ranked #160.

Arrowroot Family Office first reported a position in ABBV in Q4 2024 and has held it in 4 quarters since. The position peaked at $318K in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Arrowroot Family Office held 949 shares of AbbVie worth $239K as of Q2 2026.
  • Arrowroot Family Office sold 110 AbbVie shares in Q2 2026, an estimated $23.7K.
  • AbbVie made up 0.07% of Arrowroot Family Office's portfolio in Q2 2026, its #160 holding.
  • Arrowroot Family Office first reported a position in AbbVie in Q4 2024 and has held it in 4 quarters since.
  • Arrowroot Family Office's AbbVie position peaked at $318K in Q3 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Arrowroot Family Office's 13F filing for Q2 2026, filed 6 Aug 2026.